Biotechnology CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys Monkey studies look encouraging but show there’s still a lot to learn about the gene-editing technology. by Emily Mullin 2018-04-11T07:00:00-04:00
Biotechnology CRISPR may not cause hundreds of rogue mutations after all Researchers behind a controversial paper have admitted that their results may be wrong. by Emily Mullin 2018-03-30T16:41:00-04:00
Rewriting Life Gene-Editing Company Editas’s Ambitions Rest on Shaky Foundations The company trying to be the first to turn the powerful gene-editing tool CRISPR into medicine faces a number of hurdles. by Michael Reilly 2016-02-03T15:31:00-05:00
Rewriting Life A Scientist’s Contested History of CRISPR Eric Lander of the Broad Institute writes a history of a gene-editing technique that may be seen as partial to one side of a patent dispute. by Antonio Regalado 2016-01-19T17:33:00-05:00
Rewriting Life Big Pharma Doubles Down on CRISPR for New Drugs A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body. by Mike Orcutt 2016-01-13T00:00:00-05:00
Rewriting Life Patients Favor Changing the Genes of the Next Generation with CRISPR To people facing a devastating inherited disease, engineering humanity sounds like a good thing. by Antonio Regalado 2015-12-02T13:01:00-05:00
Rewriting Life Industry Body Calls for Gene-Editing Moratorium Gene-editing companies say research on altering the DNA of human reproductive cells is dangerous and unethical. by Antonio Regalado 2015-03-12T17:49:00-04:00
Rewriting Life 2014 in Biomedicine: Rewriting DNA, Decoding the Brain, and a GMO Paradox From genetically modified foods to gene therapy, 2014 was a big year for rewriting biology. by Antonio Regalado 2014-12-30T00:00:00-05:00
Biotechnology Who Owns the Biggest Biotech Discovery of the Century? There’s a bitter fight over the patents for CRISPR, a breakthrough new form of DNA editing. by Antonio Regalado 2014-12-04T18:00:00-05:00
Rewriting Life EmTech: Risks of Gene-Editing Drugs Need Study, Pioneer Warns One of the inventors of gene editing says scientists should proceed cautiously before testing it in people. by Antonio Regalado 2014-09-24T12:24:00-04:00
